Peptides DB
Research-centric peptide and protocol reference hub
Study 19 of 20GHRP-6 literatureInternational heart journal · Animal study · Preclinical2017

The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.

Hexarelin shows potential for protecting heart cells from damage due to ischemia/reperfusion injury in rats, but its relevance to human treatment is unclear.

Read at International heart journalAdd to compare

Where it sits

this study against the rest of the ghrp-6 corpus
2
Preclinical · this one
14
Observational
0
Open-label
1
Randomised
3
Reviews

Summary and findings

The study investigated the effects of hexarelin on cardiomyocytes in male SD rats subjected to ischemia/reperfusion injury. Rats received either hexarelin [100 μg/kg·day], ghrelin [400 μg/kg·day], or saline for 7 days following a 30-minute ischemic event. The results indicated improvements in cardiac function and reductions in malondialdehyde levels with hexarelin treatment compared to controls.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.Preclinical2017

Abstract

The authors’ words, as International heart journal supplied them

Hexarelin, a synthetic growth hormone-releasing peptide, has been proven to possess cardioprotective actions through its binding to the growth hormone secretagogue receptor (GHSR) 1a and the non-GHSR receptor CD36. However, its effect on myocardial ischemia/reperfusion (I/R) injury has not been fully clarified in vivo. We aimed to determine whether hexarelin treatment could protect cardiomyocytes from I/R injury and to examine the underlying mechanisms. In vivo hearts of male SD rats underwent 30 minutes of ischemia by left coronary artery ligation followed by reperfusion. The rats were then treated subcutaneously twice daily with hexarelin [100 μg/kg·day], ghrelin [400 μg/ kg·day], or saline for 7 days. Echocardiography, malondialdehyde detection, and histochemical staining were performed after treatment. In addition, Western blot was used to examine the expression levels of IL-1β, IL-1Ra, and IL-1RI. Our study showed that hexarelin treatment improved cardiac systolic function, decreased malondialdehyde production, and increased the number of surviving cardiomyocytes. The beneficial effects of hexarelin treatment were slightly superior to those of equimolar ghrelin treatment. We meanwhile confirmed that hexarelin induced down-regulation of IL-1β expression and up-regulation of IL-1Ra expression in I/R myocardium, which could be neutralized by the GHSR antagonist [D-Lys3]-growth hormone releasing peptide-6 ([D-Lys3]-GHRP-6). These findings suggest that hexarelin protects in vivo cardiomyocytes from I/R injury partly by modification of the IL-1 signaling pathway through the activation of cardiac GHSR1a receptors.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the GHRP-6 corpus

BA practical approach to the diagnosis of growth hormone (GH) deficiency in patients transitioning to adulthood using GH stimulation testing.Journal of pediatric endocrinology & metabolism : JPEM · 2003 · Stimulated peak serum GH concentrations <5 ng/ml if measured by polyclonal radioimmunoassays.HumanBLDH-mediated autophagic full-chain blockade for Multiple Myeloma treatment by targeting circ_0008255/miR-192-5p/ATG2A axis.Bioactive materials · 2026 · Not reported in abstract.HumanCLoss of EGFR activity in skeletal stem/progenitor cells is associated with impaired fracture healing in aged mice.Bioactive materials · 2026 · Not reported in abstract.AnimalCLong-term exploratory evaluation of an acellular biomimetic polyfascicular nerve guidance conduit for peripheral nerve repair in a rhesus macaque model.Bioactive materials · 2026 · n=3 · 94% reduction in PLCL molecular weight at 12 months.AnimalCAreca catechu L. procyanidins alleviate pulmonary fibrosis by suppressing the TGF-β/Smad/ERK cascade: Validation of a traditional herbal medicine.Journal of ethnopharmacology · 2026 · ANP significantly reduced collagen deposition (HYP), p-Smad3/4, and p-ERK levels.AnimalCIn vivo antimalarial activity and acute toxicity of organic and aqueous leaf, stem and root extracts of Ajuga integrifolia Buch.-Ham. ex D. Don.Journal of ethnopharmacology · 2026 · Organic stem extracts at 500 mg/kg/day suppressed parasite growth by 66.73%.Animal